BIOMAT Database Logo BIOMAT Database Logo

[Clinical significance of quantitative determination of lipoprotein X in patients with cholestasis (author's transl)]. 1979

S Koga, and K Yamamoto, and H Ibayashi

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Koga, and K Yamamoto, and H Ibayashi
[Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis].
March 1984, Revista medica de Chile,
S Koga, and K Yamamoto, and H Ibayashi
[The diagnosis of cholestasis: lipoprotein X (LP-X) (author's transl)].
September 1975, Wiener klinische Wochenschrift,
S Koga, and K Yamamoto, and H Ibayashi
[Quantitative determination of lipoprotein-X by phosphotungstate/Mg2+ precipitation method (author's transl)].
January 1982, Rinsho byori. The Japanese journal of clinical pathology,
S Koga, and K Yamamoto, and H Ibayashi
[Significance of serum beta-lipoprotein subfraction determination (author's transl)].
September 1981, Zhonghua xin xue guan bing za zhi,
S Koga, and K Yamamoto, and H Ibayashi
[Diagnostic value of the lipoprotein-X determination (author's transl)].
October 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
S Koga, and K Yamamoto, and H Ibayashi
Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
January 1975, Scandinavian journal of gastroenterology,
S Koga, and K Yamamoto, and H Ibayashi
[Application of the enzymatic determination of phospholipids to quantitative estimation of lipoprotein-X (author's transl)].
April 1977, Rinsho byori. The Japanese journal of clinical pathology,
S Koga, and K Yamamoto, and H Ibayashi
A method for quantitative determination of the abnormal lipoprotein of cholestasis, LP-X.
September 1974, Clinica chimica acta; international journal of clinical chemistry,
S Koga, and K Yamamoto, and H Ibayashi
[Studies on abnormal lipid metabolism in cholestasis, with special reference to occurrence of lipoprotein-X (LP-X) (AUTHOR'S TRANSL)].
December 1978, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Koga, and K Yamamoto, and H Ibayashi
[Clinical significance of dissociated cholestasis as a biological syndrome (author's transl)].
October 1981, Medicina clinica,
Copied contents to your clipboard!